Skip to main content
SpringerLink
Log in

The Impact of COVID-19 on Sports Cardiology

  • Chapter
  • First Online:
Sports Cardiology

  • 568 Accesses

Abstract

The COVID-19 pandemic in early 2020 necessitated a global shutdown of organized sports from the recreational level to the Olympic Games. Concerns of potential cardiac sequelae of COVID-19 have created significant challenges for sport and health organizations to design and implement safe return-to-play (RTP) processes for athletes. In response, American College of Cardiology expert consensus RTP screening algorithms have been generated, and updated, for athletes testing positive for COVID-19. This chapter will review the background data forming the basis and impetus for these RTP screening recommendations, provide strategies to enhance the appropriate use and interpretation of the cardiovascular diagnostic components of the screening algorithms, and present insights gained from experience with the implementation of these RTP recommendations that has allowed safe return to sport.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  1. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231–64. https://doi.org/10.1016/j.jacc.2018.08.1038.

    Article  PubMed  Google Scholar 

  2. Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and cardiovascular disease. Circulation. 2020;141(20):1648–55. https://doi.org/10.1161/CIRCULATIONAHA.120.046941.

    Article  CAS  PubMed  Google Scholar 

  3. Fried JA, Ramasubbu K, Bhatt R, et al. The variety of cardiovascular presentations of COVID-19. Circulation. 2020;141(23):1930–6. https://doi.org/10.1161/CIRCULATIONAHA.120.047164.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Sandoval Y, Januzzi JLJ, Jaffe AS. Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week. J Am Coll Cardiol. 2020;76(10):1244–58. https://doi.org/10.1016/j.jacc.2020.06.068.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Atri D, Siddiqi HK, Lang JP, Nauffal V, Morrow DA, Bohula EA. COVID-19 for the cardiologist: basic virology, epidemiology, cardiac manifestations, and potential therapeutic strategies. JACC Basic Transl Sci. 2020;5(5):518–36. https://doi.org/10.1016/j.jacbts.2020.04.002.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Lindner D, Fitzek A, Bräuninger H, et al. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. 2020. https://doi.org/10.1001/jamacardio.2020.3551.

  7. Libby P. The heart in COVID-19: primary target or secondary bystander? JACC Basic Transl Sci. 2020;5(5):537–42. https://doi.org/10.1016/j.jacbts.2020.04.001.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–7. https://doi.org/10.1002/path.1570.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–7. https://doi.org/10.1111/jth.14768.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Kim JH, Levine BD, Phelan D, et al. COVID-19 and the athletic heart: emerging perspectives on pathology, risks, and return-to-play. JAMA Cardiol. 2021;6(2):219–27. https://doi.org/10.1001/jamacardio.2020.5890.

  11. Phelan D, Kim JH, Elliott MD, et al. Screening of potential cardiac involvement in competitive athletes recovering from COVID-19: an expert consensus statement. JACC Cardiovasc Imaging. 2020;13:2635–52. https://doi.org/10.1016/j.jcmg.2020.10.005.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Maron BJ, Udelson JE, Bonow RO, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement From the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e273–80. https://doi.org/10.1161/CIR.0000000000000239.

    Article  PubMed  Google Scholar 

  13. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation. 2009;119(8):1085–92. https://doi.org/10.1161/CIRCULATIONAHA.108.804617.

    Article  PubMed  Google Scholar 

  14. Pelliccia A, Solberg EE, Papadakis M, et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 2019;40(1):19–33. https://doi.org/10.1093/eurheartj/ehy730.

    Article  PubMed  Google Scholar 

  15. Phillips M, Robinowitz M, Higgins JR, Boran KJ, Reed T, Virmani R. Sudden cardiac death in Air Force recruits. A 20-year review. JAMA. 1986;256(19):2696–9.

    Article  CAS  PubMed  Google Scholar 

  16. Kiel RJ, Smith FE, Chason J, Khatib R, Reyes MP. Coxsackievirus B3 myocarditis in C3H/HeJ mice: description of an inbred model and the effect of exercise on virulence. Eur J Epidemiol. 1989;5(3):348–50. https://doi.org/10.1007/BF00144836.

    Article  CAS  PubMed  Google Scholar 

  17. Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020. https://doi.org/10.1001/jamacardio.2020.3557.

  18. Rajpal S, Tong MS, Borchers J, et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol. 2020; https://doi.org/10.1001/jamacardio.2020.4916.

  19. Heart condition linked with COVID-19 fuels Power 5 concern about season’s viability. https://www.espn.com/college-football/story/_/id/29633697/heart-condition-linked-covid-19-fuels-power-5-concern-season-viability.

  20. Baggish A, Drezner JA, Kim J, Martinez M, Prutkin JM. Resurgence of sport in the wake of COVID-19: cardiac considerations in competitive athletes. Br J Sports Med. 2020. https://doi.org/10.1136/bjsports-2020-102516.

  21. Vago H, Dohy Z, Merkely B. Cardiac magnetic resonance findings in patients recovered from COVID-19: initial experiences in elite athletes. JACC Cardiovasc Imaging. 2020;S1936-878X:31021–4.

    Google Scholar 

  22. Brito DM, Yanamala N, Heenaben P, et al. High prevalence of pericardial involvement in college student-athletes recovering from COVID-19. JACC Cardiovasc Imaging. 2020;S1936-878X:30946–3.

    Google Scholar 

  23. Starekova J, Bluemke DA, William S Bradham WS, et al. Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging. JAMA Cardiol. 2021;14:e207444. https://doi.org/10.1001/jamacardio.2020.7444. Online ahead of print.

  24. Baggish AL, Battle RW, Beaver TA, et al. Recommendations on the use of multimodality cardiovascular imaging in young adult competitive athletes: a report from the American Society of Echocardiography in collaboration with the Society of Cardiovascular Computed Tomography and the Society for Car. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 2020;33(5):523–49. https://doi.org/10.1016/j.echo.2020.02.009.

    Article  Google Scholar 

  25. Shave R, Baggish A, George K, et al. Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications. J Am Coll Cardiol. 2010;56(3):169–76. https://doi.org/10.1016/j.jacc.2010.03.037.

    Article  CAS  PubMed  Google Scholar 

  26. La Gerche A, Burns AT, Mooney DJ, et al. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J. 2012;33(8):998–1006. https://doi.org/10.1093/eurheartj/ehr397.

    Article  CAS  PubMed  Google Scholar 

  27. Phelan D, Kim JH, Chung EH. A game plan for the resumption of sport and exercise after coronavirus disease 2019 (COVID-19) infection. JAMA Cardiol. 2020. https://doi.org/10.1001/jamacardio.2020.2136.

  28. Schellhorn P, Klingel K, Burgstahler C. Return to sports after COVID-19 infection: do we have to worry about myocarditis? Eur Heart J. 2020. https://doi.org/10.1093/eurheartj/ehaa448.

  29. Wilson MG, Hull JH, Rogers J, et al. Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection: a practical guide for sport and exercise medicine physicians. Br J Sports Med. 2020;54(19):1157–61. https://doi.org/10.1136/bjsports-2020-102710.

    Article  PubMed  Google Scholar 

  30. Bhatia RT, Marwaha S, Malhotra A, et al. Exercise in the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) era: a question and answer session with the experts endorsed by the section of sports cardiology & exercise of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol. 2020;27(12):1242–51. https://doi.org/10.1177/2047487320930596.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Phelan D, Kim JH, Elliot MD, et al. Screening of potential cardiac involvement in competitive athletes recovering from COVID-19: an expert consensus statement, vol. 13; 2020. p. 2635–52.

    Google Scholar 

  32. Baggish AL, Levine BD. Icarus and sports after COVID 19: too close to the Sun? Circulation. 2020. https://doi.org/10.1161/CIRCULATIONAHA.120.048335.

  33. Donnellan E, Phelan D. Biomarkers of cardiac stress and injury in athletes: what do they mean? Curr Heart Fail Rep. 2018;15(2):116–22. https://doi.org/10.1007/s11897-018-0385-9.

    Article  CAS  PubMed  Google Scholar 

  34. Kleiven Ø, Omland T, Skadberg Ø, et al. Race duration and blood pressure are major predictors of exercise-induced cardiac troponin elevation. Int J Cardiol. 2019;283:1–8. https://doi.org/10.1016/j.ijcard.2019.02.044.

    Article  PubMed  Google Scholar 

  35. Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802–10. https://doi.org/10.1001/jamacardio.2020.0950.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Morgera T, Di Lenarda A, Dreas L, et al. Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes. Am Heart J. 1992;124(2):455–67. https://doi.org/10.1016/0002-8703(92)90613-z.

    Article  CAS  PubMed  Google Scholar 

  37. Engel DJ, Schwartz A, Homma S. Athletic cardiac remodeling in US professional basketball players. JAMA Cardiol. 2016;1(1):80–7. https://doi.org/10.1001/jamacardio.2015.0252.

    Article  PubMed  Google Scholar 

  38. Abergel E, Chatellier G, Hagege AA, et al. Serial left ventricular adaptations in world-class professional cyclists: implications for disease screening and follow-up. J Am Coll Cardiol. 2004;44(1):144–9. https://doi.org/10.1016/j.jacc.2004.02.057.

    Article  PubMed  Google Scholar 

  39. Teske AJ, Prakken NH, De Boeck BW, et al. Echocardiographic tissue deformation imaging of right ventricular systolic function in endurance athletes. Eur Heart J. 2009;30(8):969–77. https://doi.org/10.1093/eurheartj/ehp040.

    Article  PubMed  Google Scholar 

  40. Han Y, Chen T, Bryant J, et al. Society for Cardiovascular Magnetic Resonance (SCMR) guidance for the practice of cardiovascular magnetic resonance during the COVID-19 pandemic. J Cardiovasc Magn Reson. 2020;22(1):26. https://doi.org/10.1186/s12968-020-00628-w.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Huang L, Zhao P, Tang D, et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging. 2020:3427. https://doi.org/10.1016/j.jcmg.2020.05.004.

  42. Sharma S, Drezner JA, Baggish A, et al. International recommendations for electrocardiographic interpretation in athletes. J Am Coll Cardiol. 2017;69(8):1057–75. https://doi.org/10.1016/j.jacc.2017.01.015.

    Article  PubMed  Google Scholar 

  43. Martinez MW, Tucker AM, OJ Bloom, et al. Prevalence of Inflammatory Heart Disease Among Professional Athletes with Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening. JAMA Cardiol. 2021;4. https://doi.org/10.1001/jamacardio.2021.0565.

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Columbia University Irving Medical Center, New York, NY, USA

    Bradley Lander & David J. Engel

  2. Sport Cardiology Center, Hypertrophic Cardiomyopathy Center, Atrium Health Sanger Heart & Vascular Institute, Charlotte, NC, USA

    Dermot M. Phelan

Authors
  1. Bradley Lander
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David J. Engel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dermot M. Phelan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David J. Engel .

Editor information

Editors and Affiliations

  1. Division of Cardiology, Columbia University Irving Medical Center, New York, NY, USA

    David J. Engel

  2. Sports Cardiology Center, Hypertrophic Cardiomyopathy Center Atrium Health Sanger Heart & Vascular Institute, Charlotte, NC, USA

    Dermot M. Phelan

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lander, B., Engel, D.J., Phelan, D.M. (2021). The Impact of COVID-19 on Sports Cardiology. In: Engel, D.J., Phelan, D.M. (eds) Sports Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-030-69384-8_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-69384-8_23

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-69383-1

  • Online ISBN: 978-3-030-69384-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation